Oct 9 Genoptix Inc, which provides diagnostic
services to hematologists and oncologists, on Tuesday
registered its initial public offering of 5 million shares for
an estimated price of $14 to $16 per share.
In an amended filing with the U.S Securities and Exchange
Commission, the company said it plans to sell about 4.3 million
shares and the rest will be sold by its stockholders.
Genoptix said it expects to use the estimated net proceeds
of about $57.7 million to establish a second laboratory
facility and expand backup systems, repay debt, among other
The Carlsbad, California-based company is seeking a Nasdaq
listing under the symbol "GXDX". Lehman Brothers, Banc of
America Securities LLC and Cowen & Co will underwrite the IPO.
The company said it granted the underwriters a 30-day
option to buy up to an additional 750,000 shares from the
(Reporting by Deepti Chaudhary in Bangalore)